The WEB-RADR project developed three mobile applications (apps) enabling patients, caregivers, and healthcare professionals to report adverse drug reactions (ADRs) and receive up-to-date information and news alerts. UK (Yellow Card) - launched 14 July 2015 Netherlands (LAREB) - launched 29 January 2016 Croatia (HALMED) - launched 18 May 2016 Key features: A convenient alternative to paper or electronic…
El metamizole s’associa a un risc de dany hepàtic gairebé 2 vegades superior a paracetamol i augmenta el risc de dany fins a 5 vegades respecte a no consumir el fàrmac. És més freqüent en dones i en tractaments a partir de 9 dies de durada. Per aquest motiu, se n’hauria de restringir l’ús a casos de dolor agut.
Hedenmalm K, Pacurariu A, Slattery J, Kurz X, Candore G, Flynn R. Is There an Increased Risk of Hepatotoxicity with Metamizole? A Comparative Cohort Study in Incident Users. Drug Saf. 2021 Sep;44(9):973-985.
Cal informar les dones en edat fèrtil i que poden estar embarassades dels riscos de l’ús de pregabalina, que l’embaràs ha de ser planificat i que han d’emprar mesures anticonceptives durant el tractament. Sempre s’hauran de ponderar els beneficis i els riscos del tractament i, si cal tractar amb pregabalina durant l’embaràs, es farà a la dosi més baixa possible i fent una supervisió més estricta de la persona.
Pregabalin (Lyrica): findings of safety study on risks during pregnancy. Drug Safety Update. Medicines and Healthcare products Regulatory Agency. Published 19 April 2022.
The Reporting of A Disproportionality analysis for drUg Safety signal detection using spontaneously reported adverse events in Pharmacovigilance (READUS-PV) is an international collaborative which aim at developing the first reporting recommendations for studies using disproportionality analyses in databases of spontaneously reported adverse events. Our goal is therefore to enhance transparency by providing researchers with the minimum reporting…